3 ms·

In his blog, he discusses Keytruda. https://jakeseliger.com/2023/12/19/what-if-things-go-right-with-the-carcinoma-treatment-how-long-we-expect-to-live-affects-h

• melling 2y ago
  I see where he discusses it. He said it only works for a small group and not for him. He’s mentions trying drugs that target EGFR mutations, which I believe tries to stop the blood supply to the tumor. Targeting specific protein receptors, like HER2 in breast cancer, seems to be promising. https://my.clevelandclinic.org/health/diseases/25213-her2-positive-breast-cancer https://my.clevelandclinic.org/health/diseases/25213-her2-po... RAS is a target for (some) colon and pancreatic cancers: https://www.cancer.gov/research/key-initiatives/ras#:~:text=More%20than%2030%20percent%20of,the%20RAS%20family%20of%20genes https://www.cancer.gov/research/key-initiatives/ras#:~:text=....